Literature DB >> 22427232

Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island.

Nickolas D Zaller1, Michael A Yokell, Sandeep M Nayak, Jeannia J Fu, Alexander R Bazazi, Josiah D Rich.   

Abstract

Access to sterile syringes for injection drug users (IDUs) is a critical part of a comprehensive strategy to combat the transmission of HIV, hepatitis C virus, and other bloodborne pathogens. Understanding IDUs' experiences and attitudes about syringe acquisition is crucial to ensuring adequate syringe supply and access for this population. This study sought to assess and compare IDUs' syringe acquisition experiences and attitudes and HIV risk behavior in two neighboring states, Massachusetts (MA) and Rhode Island (RI). From March 2008 to May 2009, we surveyed 150 opioid IDUs at detoxification facilities in MA and RI, stratified the sample based on where respondents spent most of their time, and generated descriptive statistics to compare responses among the two groups. A large proportion of our participants (83%) reported pharmacies as a source of syringe in the last 6 months, while only 13% reported syringe exchange programs (SEPs) as a syringe source. Although 91% of our sample reported being able to obtain all of the syringes they needed in the past 6 months, 49% had used syringes or injection equipment previously used by someone else in that same time period. In comparison to syringe acquisition behaviors reported by patients of the same detoxification centers in 2001-2003 (data reported in previous publication), we found notable changes among MA participants. Our results reveal that some IDUs in our sample are still practicing high-risk injection behaviors, indicating a need for expanded and renewed efforts to promote safer injection behavior among IDUs. Our findings also indicate that pharmacies have become an important syringe source for IDUs and may represent a new and important setting in which IDUs can be engaged in a wide array of health services. Efforts should be made to involve pharmacists in providing harm reduction and HIV prevention services to IDUs. Finally, despite limited SEP access (especially in MA), SEPs are still used by approximately one of the three IDUs in our overall sample.

Entities:  

Mesh:

Year:  2012        PMID: 22427232      PMCID: PMC3535136          DOI: 10.1007/s11524-012-9669-7

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  19 in total

1.  Strategies to optimize the impact of needle exchange programs.

Authors:  J D Rich; L L Strong; M Mehrotra; G Macalino
Journal:  AIDS Read       Date:  2000-07

Review 2.  Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users.

Authors:  D R Gibson; N M Flynn; D Perales
Journal:  AIDS       Date:  2001-07-27       Impact factor: 4.177

Review 3.  Structural interventions to reduce HIV transmission among injecting drug users.

Authors:  D C Des Jarlais
Journal:  AIDS       Date:  2000-06       Impact factor: 4.177

Review 4.  Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal.

Authors:  T Stephen Jones; Phillip O Coffin
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

5.  HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services.

Authors:  Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Lucia V Torian; Sara Beatrice; Judith Milliken; Donna Mildvan; Stanley Yancovitz; Samuel R Friedman
Journal:  Am J Public Health       Date:  2005-06-28       Impact factor: 9.308

6.  Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program.

Authors:  Enrique R Pouget; Sherry Deren; Crystal M Fuller; Shannon Blaney; James M McMahon; Sung-Yeon Kang; Stephanie Tortu; Jonny F Andia; Don C Des Jarlais; David Vlahov
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-01       Impact factor: 3.731

Review 7.  Self-report among injecting drug users: a review.

Authors:  S Darke
Journal:  Drug Alcohol Depend       Date:  1998-08-01       Impact factor: 4.492

Review 8.  Interventions to prevent HIV risk behaviors.

Authors: 
Journal:  NIH Consens Statement       Date:  1997 Feb 11-13

9.  Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers--Connecticut, 1992-1993.

Authors:  S L Groseclose; B Weinstein; T S Jones; L A Valleroy; L J Fehrs; W J Kassler
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-09-01

10.  Validity of self-reports and drug use among young people seeking treatment for substance abuse or dependence.

Authors:  Elisabet Solbergsdottir; Gudbjorn Bjornsson; Larus S Gudmundsson; Torarinn Tyrfingsson; Jakob Kristinsson
Journal:  J Addict Dis       Date:  2004
View more
  3 in total

Review 1.  Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.

Authors:  Brandon D L Marshall; Traci C Green; Jesse L Yedinak; Scott E Hadland
Journal:  Int J Drug Policy       Date:  2016-02-04

2.  Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.

Authors:  Thomas J Stopka; Ashley Donahue; Marguerite Hutcheson; Traci C Green
Journal:  J Am Pharm Assoc (2003)       Date:  2017-02-08

3.  Pharmacists' role in harm reduction: a survey assessment of Kentucky community pharmacists' willingness to participate in syringe/needle exchange.

Authors:  Amie Goodin; Amanda Fallin-Bennett; Traci Green; Patricia R Freeman
Journal:  Harm Reduct J       Date:  2018-01-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.